Clinical research shows that HMGB-1 can be secreted passively by injured and necrotic cells or actively by activated immune cells under the stimulation of cytokines, while it can also be released in large quantities in various pathological processes such as sepsis, tumours, infections, and shock [18]. The gene discussed is HMGB1; the disease is neoplasm.